Cleared Traditional

K041477 - PATHFINDER

K041477 is an FDA 510(k) clearance for PATHFINDER, manufactured by Armstrong Healthcare Limited. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 189-day FDA review.

K041477 · Armstrong Healthcare Limited · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2004
Decision
189d
Days
Class 2
Risk

K041477 is an FDA 510(k) clearance for the PATHFINDER. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Armstrong Healthcare Limited (High Wycombe, GB). The FDA issued a Cleared decision on December 9, 2004 after a review of 189 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Armstrong Healthcare Limited devices

FDA 510(k) Submission Details - K041477

510(k) Number K041477 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2004
Decision Date December 09, 2004
Days to Decision 189 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 148d · This submission: 189d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 259
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K041477.
VECTORVISION OSTEOTOMY
K042513 · Brainlab AG · Feb 2005
NAVIGUS NEXDRIVE, MODEL MI-3000
K043091 · Image-Guided Neurologics, Inc. · Feb 2005
VECTORVISION ACL
K042512 · Brainlab AG · Jan 2005
IPLAN!
K041703 · Brainlab AG · Oct 2004
KOLIBRI IMAGE GUIDED SURGERY SYSTEM
K042391 · Brainlab AG · Oct 2004
VECTORVISION UNI-KNEE
K041899 · Brainlab AG · Oct 2004